Connect your AI

Doximity DOCS 2028

2028 at other companies

Veeva SystemsVEEV

——

SolventumSOLV

——

Cardinal HealthCAH

——

McKessonMCK

——

Medline, Inc. MDLN

——

Other financials

Income statement

Revenue$145.4M+5.1%

Gross profit$126.0M+1.7%

Operating income$24.8M-49.0%

Net income$19.1M-69.4%

EPS (diluted)$0.10-67.7%

Balance sheet

Cash & equivalents$219.2M+4.6%

Total debt$10.2M-17.8%

Total equity$950.8M-12.2%

Total assets$1.1B-11.1%

Cash flow

Operating cash flow$109.5M+11.2%

CapEx-—

Free cash flow$81.6M-17.1%

Valuation

Market cap$3.75B-60.5%

Profitability

Gross margin89.1%-1.1pp

Operating margin33.3%-6.6pp

Net margin30.4%-8.7pp

FCF margin50.6%+2.7pp

Returns & leverage

Return on equity19.3%-3.2pp

Debt / equity0×0.0×

Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo.

The official record: Doximity’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's 2028.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Doximity's 2028?: Doximity (DOCS) reported 2028 of $7.76M in Q4 2025.
How has Doximity's 2028 changed year-over-year?: Doximity's 2028 increased by 93.6% year-over-year, from $4.01M to $7.76M.